Alnylam adds a slate of new executives; Thomas Insel is leaving Verily; Akari CEO Gur Roshwalb placed on leave
→ Scott Gottlieb was sworn in as America’s 23rd Commissioner of Food and Drugs yesterday.
— Tom Price, M.D. (@SecPriceMD) May 11, 2017
→ RNAi biotech Alnylam named a slate of new appointments including Manmeet Soni as CFO, who arrives by way of Ariad and Pharmacyclics; Theresa Heggie as senior vice president, head of Europe and Canada; Peter Smith, senior vice president, early development; plus former Celgene and BIO executive Alan Eisenberg as vice president, global public policy and government relations.
→ Akari Therapeutics CEO Gur Roshwalb was placed on administrative leave.
— Adam Feuerstein (@adamfeuerstein) May 11, 2017
→ Aravive Biologics named Stephen Eck as its president and CEO.
→ Thomas Insel is leaving Verily.
→ Bob Vonderheide is the new director of the Abramson Cancer Center of the University of Pennsylvania.
→ David Ford is leaving Sanofi Genzyme to join Intercept Pharmaceuticals.